Pharmacology, Toxicology and Pharmaceutical Science
Acute Kidney Failure
11%
Adverse Event
22%
Aminoglycoside
13%
Amphotericin B
11%
Antibiotic Agent
22%
Antibiotics
28%
Antifungal Agent
19%
Antifungal Therapy
7%
Antiinfective Agent
60%
Antimicrobial Therapy
9%
Aspergillus
10%
Asthma
17%
Beta Lactam
17%
Blood Clotting Disorder
11%
Candida
7%
Cefepime
10%
Clinical Study
9%
Colistimethate
10%
Controlled Clinical Trial
8%
Coronavirinae
29%
Disease
31%
Hospital Acquired Pneumonia
10%
Hospital Infection
12%
Immunocompromised Patient
7%
Infection
44%
Infectious Agent
15%
Inflammation
10%
Invasive Aspergillosis
13%
Isavuconazole
11%
Meningoencephalitis
23%
Normal Human
15%
Pharmacodynamic Parameter
9%
Pharmacodynamics
47%
Pharmacokinetics
69%
Pharmacokinetics
8%
Piperacillin
25%
Piperacillin Plus Tazobactam
22%
Respiratory Tract
10%
Respiratory Tract Infection
8%
SARS Coronavirus
11%
Sepsis
15%
Tazobactam
12%
Therapeutic Drug Monitoring
13%
Triazole
8%
Vancomycin
11%
Ventilator Associated Pneumonia
45%
Volatile Organic Compound
11%
Von Willebrand Factor
11%
Von Willebrand Factor Cleaving Proteinase
11%
Voriconazole
11%
Medicine and Dentistry
Adverse Event
11%
Aminoglycoside
13%
Anti-biotics
23%
Antibiotic Therapy
8%
Antifungal Agent
8%
Antiinfective Agent
28%
Antimicrobial Therapy
9%
Artificial Respiration
19%
Aspergillus
8%
Asthma
13%
B Cell
11%
Beta Lactam
11%
Bloodstream Infection
15%
Breathing
15%
Candidemia
11%
Cell Function
11%
Coagulopathy
11%
Cohort Analysis
17%
Colistimethate
13%
COVID-19
100%
COVID-19 Therapy
17%
Cross-Link
11%
Diagnosis
14%
Diagnostic Test
11%
Dyspnea
8%
Extracorporeal Membrane Oxygenation
18%
Fibrinolysis
11%
Hospital-Acquired Pneumonia
10%
Infection
21%
Intensive Care
25%
Lung Lavage
7%
Mental Capacity
11%
Meta-Analysis
21%
Multidrug-Resistant Gram-Negative Bacteria
11%
Noninvasive Ventilation
7%
Observational Study
7%
Odds Ratio
13%
Pathogen
11%
Pharmacodynamics
15%
Pharmacokinetics
15%
Pleurodesis
11%
Pneumothorax
11%
Respiratory Failure
12%
Sepsis
27%
T Cell
12%
Tocilizumab
11%
Tracheobronchial Toilet
12%
Ventilator-Associated Pneumonia
37%
Von Willebrand Factor
11%
Von Willebrand Factor Cleaving Proteinase
11%
Immunology and Microbiology
Allergic Bronchopulmonary Aspergillosis
5%
Ampicillin Resistance
5%
Antifungal Activity
5%
Antimicrobial Resistance
10%
Aspergillus fumigatus
5%
Asthma
24%
B Cell
11%
Blood Plasma
5%
Candida
5%
Carbapenem Resistant Enterobacteriaceae
5%
Cell Function
11%
Cochrane Library
13%
Coculture
5%
Colistin
5%
COVID-19
52%
Cross Linking
11%
Data Synthesis
5%
Enterobacter Cloacae
5%
Escherichia coli
5%
Fibrinolysis
11%
Gram-Negative Bacteria
5%
Humor
5%
Immune Response
7%
Induced Pluripotent Stem Cell
5%
Interleukin-6 Receptor
5%
Kidney Transplantation
5%
Maximum Concentration
5%
Medline
13%
Mental Capacity
13%
Meropenem/Vaborbactam
5%
Microbiome
5%
Minimum Concentration
11%
Minimum Inhibitory Concentration
10%
Mortality
5%
Myeloid
5%
Nebulization
5%
Normal Human
5%
Organoid
5%
Pharmacodynamics
17%
Pharmacokinetics
12%
Phenotype
11%
Pseudomonas aeruginosa
5%
Sarilumab
5%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Sputum
11%
T Cell
13%
TLR7
5%
Tocilizumab
5%
Wild Type
5%
